Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OPGN

OpGen (OPGN)

OpGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPGN
DateTimeSourceHeadlineSymbolCompany
08/08/20174:01PMGlobeNewswire Inc.OpGen Reports 2017 Second Quarter Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
08/02/20177:30AMGlobeNewswire Inc.OpGen Announces Date of Second Quarter 2017 Financial Results Conference CallNASDAQ:OPGNOpGen Inc
07/25/20175:54PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:OPGNOpGen Inc
07/25/20175:53PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:OPGNOpGen Inc
07/25/20174:19PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OPGNOpGen Inc
07/21/20174:41PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
07/19/20179:25AMGlobeNewswire Inc.OpGen Announces Closing of $10 Million Public OfferingNASDAQ:OPGNOpGen Inc
07/18/20174:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
07/18/20174:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
07/18/20173:53PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OPGNOpGen Inc
07/14/20175:30PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
07/14/20175:27PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:OPGNOpGen Inc
07/13/20176:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OPGNOpGen Inc
07/13/20176:00AMGlobeNewswire Inc.OpGen Announces Pricing of $10.0 Million Public OfferingNASDAQ:OPGNOpGen Inc
07/12/20171:28PMGlobeNewswire Inc.OpGen Acuitas® MDRO Gene Test Approved by NY State Department of HealthNASDAQ:OPGNOpGen Inc
07/11/201710:46AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:OPGNOpGen Inc
07/10/20177:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
07/10/20177:46PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:OPGNOpGen Inc
07/10/20175:06PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OPGNOpGen Inc
07/10/20171:45PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:OPGNOpGen Inc
07/06/20174:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
06/29/20176:03AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:OPGNOpGen Inc
06/28/20175:24PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OPGNOpGen Inc
06/22/20172:33PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
06/20/20174:23PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:OPGNOpGen Inc
06/19/20174:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
06/19/20178:00AMGlobeNewswire Inc.OpGen Signs Supply Agreement to Use Thermo Fisher Scientific’s Technology to Advance Acuitas® Rapid TestNASDAQ:OPGNOpGen Inc
06/15/20173:03PMGlobeNewswire Inc.OpGen’s Acuitas® Detection Technology Utilized in Publication Revealing Prevalence of CRE in Washington D.C. Healthcare Fa...NASDAQ:OPGNOpGen Inc
06/12/20174:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
06/12/20174:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
 Showing the most relevant articles for your search:NASDAQ:OPGN